THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsProspectively registered double-blind randomized sham-controlled clinical trial

Double-blind, randomized clinical trial targeting theta oscillations with transcranial alternating current stimulation (tACS) for cognitive control in male methamphetamine patients.

After a 15-session theta-frequency stimulation program, participants showed improvements on laboratory measures of proactive and reactive cognitive control. The finding is promising but does not yet establish reduced drug use or durable real-world benefit.

Tian Y, Jiang L, Gang X, Chen M, Tang S, Wang X, Zhang X, Wang D.
Molecular psychiatry · Publication date: 2026-09-29
Added to site: 2026-10-01
DOI: 10.1038/s41380-026-03900-0

Electronic publication date verified in PubMed and Crossref. The record was indexed after the prior portal search, and this source date is separate from the site's addition date.

Modalities
tACS, EEG, Neuromodulation
Clinical focus
Methamphetamine use disorder, Cognitive control, Frontal midline theta
Population
Men with DSM-5 methamphetamine use disorder
Sample
68 men enrolled; 56 completed all procedures and were included in the final analysis
Intervention / method
Fifteen consecutive daily sessions of 2 mA theta-frequency tACS using an FCz-Pz montage, with conditional stop-signal testing and concurrent EEG
Comparator
Sham stimulation

Clinician summary

The abstract reports improved preparation cost (p=0.001) and inhibition rate (p=0.003), enhanced late-stage proactive-control theta power (p=0.026), and restored theta-performance coupling (p=0.04). Reactive-control theta activity did not change significantly.

How to interpret the findings

Twelve of 68 enrolled participants were excluded from the final analysis. The abstract does not provide allocation-specific denominators, effect sizes, adverse-event results, craving or substance-use outcomes, or follow-up beyond the intervention. The all-male sample limits generalizability.

Equipment and disclosures

The study used 2 mA theta-tACS with an FCz-Pz montage and concurrent EEG; device manufacturer and detailed stimulation waveform were not available in the checked abstract.

The authors declared no competing interests. The indexed record reports China Postdoctoral Science Foundation support and prospective registration at ClinicalTrials.gov, NCT06292156.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-10-01

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.